50 results
8-K
IKT
Inhibikase Therapeutics Inc
20 May 24
Inhibikase Therapeutics Announces Pricing of Registered Direct Offering and Warrant
8:55am
, 2024, the Company entered into a letter agreement (the “Inducement Letter”) with the Purchaser who is an existing long-term investor in the Company
8-K
EX-99.1
85qd3banyx6rdfi3 5b
18 Apr 24
Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
9:46pm
424B5
lar0z6h
1 Feb 24
Prospectus supplement for primary offering
4:49pm
424B3
19jmrx3wsmx9pbqemi
4 Apr 23
Prospectus supplement
4:57pm
POS AM
g9k7eoo4ircu8o55
31 Mar 23
Prospectus update (post-effective amendment)
4:11pm